Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02694679 · ClinicalTrials.gov registry record · NA
Randomized Controlled Trial of Social Network Targeting in Honduras
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 31,195
- Enrollment target
NCT02694679: Completed NA study, sponsored by Yale University.
NCT02694679 is a NA study that has completed, run by Yale University. The registered enrollment target is 31,195 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2123% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02694679, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31,195 participants
- Enrollment target
Study Summary
Social network targeting strategies can be used to improve the delivery and uptake of health interventions. We will enroll approximately 30,000 individuals into a randomized controlled trial of different targeting algorithms in order to explore how social network dynamics affect the uptake, diffusion, and group-level normative reinforcement of key neonatal and infant health behaviors and attitudes in 176 rural villages in the Copan region of Honduras. Our goal is to develop methods by which global health practitioners can exploit face-to-face social network interactions in order to maximize uptake of neonatal and infant health interventions. The villages will be randomly assigned to 16 cells of 11 villages each in a 2 x 8 factorial design of different targeting algorithms.
Interventions
- BEHAVIORAL CBNH
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31,195 participants |
| Start Date | 2015-06 |
| Est. Completion | 2020-01 |
| Phase | NA |
What the finished NCT02694679 record still lists
NCT02694679 is an interventional study that assigns participants to a tested intervention. Its 31,195 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2123% higher).
The record links to 0 conditions, and to 1 intervention - of which CBNH is the first listed.
NCT02694679 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02694679 about?
NCT02694679 is a clinical study titled "Randomized Controlled Trial of Social Network Targeting in Honduras". Social network targeting strategies can be used to improve the delivery and uptake of health interventions. We will enroll approximately 30,000 individuals into a randomized controlled trial of different targeting algorithms in order to explore how social network dynamics affect the uptake, diffusio...
What is the current status of trial NCT02694679?
This trial is currently completed. It is a NA study. The enrollment target is 31,195 participants. The study started on 2015-06. Estimated completion is 2020-01.
What interventions are being tested in trial NCT02694679?
The interventions under investigation include: CBNH (BEHAVIORAL).
Who is sponsoring clinical trial NCT02694679?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02694679's enrollment target sits among peer trials
31,195 8th of 2000 higher than 1,993 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07282665 · 32,000 participants · Phase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- NCT03689595 · 30,000 participants
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia